Mealey's (January 8, 2020, 9:33 AM EST) -- WASHINGTON, D.C. — The Judicial Panel on Multidistrict Litigation (JPMDL) on Dec. 18 expanded the valsartan multidistrict litigation to include losartan and irbesartan, all high blood pressure drugs allegedly containing N-nitrosodimethylamine (NDMA), a potential carcinogen (In Re: Valsartan, Losartan and Irbesartan Products Liability Litigation, MDL Docket No. 2875, JPMDL)....